Delos Pharmaceuticals Company
%20.jpg)
Delos Pharmaceuticals, Inc. discovers and develops novel polyketide-based therapies to treat chronic disease. The company focuses on novel biological mechanisms that can be used to treat aging-related disease by addressing the basis for disease initiation and progression, such as oxidative, cellular, and environmental stress. Delos Pharmaceuticals, Inc. was incorporated in 2012 and is based in Novato, California.
Founded Date:
2012-01-01
Last Funding Type:
Seed
Headquarters:
California, Kentucky, United States
Investors Number:
3
Technology:
NeuroTech
Employee Number:
1-10
Industry:
Biopharma, Pharmaceutical
Funding Status:
Seed
Total Funding:
Â¥70M